ArticleCancers2020

Abundance of Regulatory T Cell (Treg) as a Predictive Biomarker for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.

Masanori Oshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.